First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18

BACKGROUND: This is the first clinical trial in the global pediatric clinical development program for the use of the analgesic tapentadol in children and adolescents. PATIENTS AND METHODS: This multicenter, open-label clinical trial investigated pharmacokinetics, safety and tolerability, and efficac...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Pain Res
Auteurs principaux: Finkel, Julia C, Goldberg, Jutta, Rosenburg, Ronald, Ariyawansa, Jay, Sun, Tao, Ochs-Ross, Rachel, Zannikos, Peter, Zhang, Liping, Etropolski, Mila
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6610295/
https://ncbi.nlm.nih.gov/pubmed/31303784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S197348
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires